Company: BGLC
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001477932-25-002725
Chunk: 683

Company: BioNexus Gene Lab Corp
Filing Date: 2025-04-15
Form: 10-K
Item: Item 2
Chunk 683
---
 of our executive officers and directors; and (iii) our directors and executive officers as a group. Except as otherwise indicated, each of the stockholders listed below has sole voting and investment power over the shares beneficially owned. The information is based on 17,967,663 shares of common stock issued and outstanding as of this filing.

Name and address of beneficial owners Amount andnature ofbeneficialownership ofCommon Stock  Approximatepercentage ofoutstandingCommon Stock (1)        Resigned Directors and Named Executive Officers:      Koon Wai Wong (2)  100   0.00%Wei Foong Lim (3)  362,936   2.02%All directors and executive officers as a group (2 persons)                 New Directors and Named Executive Officers:        Jook Yuen Low (4)  12,616   0.00%         Directors and Named Executive Officers:        Su-Leng Tan Lee (5)  -   - Muhammad Azrul bin Abdul Hamid (6)  -   - Chee Keong Yap (7)  -   - All directors and executive officers as a group (3 persons)  504,703   2.84%         5% or Greater Stockholders        Soo Kow Lai (8)  1,250,001   6.96%Chan Chong Wong (9)  1,031,427   5.74%Choong-Chin Liew (10)  1,666,667   9.28%Kim Hai Wong (11)  900,872   5.01%

(1) Beneficial Ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Each of the beneficial owners listed above has ownership of and voting power and investment power with respect to our Common stock or Preferred Shares. For each beneficial owner above, any options exercisable within 60 days have been included in the denominator.(2)The address for Koon Wai Wong is No.4, Jalan CJ 1/6 Kawasan Perusahaan 43200 Majlis Perbandaran Kajang Selangor, Malaysia. Shares held in registered and street name with broker.(3)The address for Wei Foong Lim is No.4, Jalan CJ 1